537 related articles for article (PubMed ID: 16510563)
1. Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate.
Khan N; Afaq F; Saleem M; Ahmad N; Mukhtar H
Cancer Res; 2006 Mar; 66(5):2500-5. PubMed ID: 16510563
[TBL] [Abstract][Full Text] [Related]
2. Green tea polyphenol EGCG suppresses cigarette smoke condensate-induced NF-kappaB activation in normal human bronchial epithelial cells.
Syed DN; Afaq F; Kweon MH; Hadi N; Bhatia N; Spiegelman VS; Mukhtar H
Oncogene; 2007 Feb; 26(5):673-82. PubMed ID: 16862172
[TBL] [Abstract][Full Text] [Related]
3. Microarray-assisted pathway analysis identifies mitogen-activated protein kinase signaling as a mediator of resistance to the green tea polyphenol epigallocatechin 3-gallate in her-2/neu-overexpressing breast cancer cells.
Guo S; Lu J; Subramanian A; Sonenshein GE
Cancer Res; 2006 May; 66(10):5322-9. PubMed ID: 16707458
[TBL] [Abstract][Full Text] [Related]
4. Green tea polyphenol epigallocatechin-3 gallate inhibits Her-2/neu signaling, proliferation, and transformed phenotype of breast cancer cells.
Pianetti S; Guo S; Kavanagh KT; Sonenshein GE
Cancer Res; 2002 Feb; 62(3):652-5. PubMed ID: 11830514
[TBL] [Abstract][Full Text] [Related]
5. Epigallocatechin-3-Gallate suppresses early stage, but not late stage prostate cancer in TRAMP mice: mechanisms of action.
Harper CE; Patel BB; Wang J; Eltoum IA; Lamartiniere CA
Prostate; 2007 Oct; 67(14):1576-89. PubMed ID: 17705241
[TBL] [Abstract][Full Text] [Related]
6. (-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis.
Shirakami Y; Shimizu M; Adachi S; Sakai H; Nakagawa T; Yasuda Y; Tsurumi H; Hara Y; Moriwaki H
Cancer Sci; 2009 Oct; 100(10):1957-62. PubMed ID: 19558547
[TBL] [Abstract][Full Text] [Related]
7. Epigallocatechin-3-gallate, a green-tea polyphenol, suppresses Rho signaling in TWNT-4 human hepatic stellate cells.
Higashi N; Kohjima M; Fukushima M; Ohta S; Kotoh K; Enjoji M; Kobayashi N; Nakamuta M
J Lab Clin Med; 2005 Jun; 145(6):316-22. PubMed ID: 15976760
[TBL] [Abstract][Full Text] [Related]
8. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
[TBL] [Abstract][Full Text] [Related]
9. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
Pan MH; Lin CC; Lin JK; Chen WJ
J Agric Food Chem; 2007 Jun; 55(13):5030-7. PubMed ID: 17539658
[TBL] [Abstract][Full Text] [Related]
10. Combinatorial effect of epigallocatechin-3-gallate and TRAIL on pancreatic cancer cell death.
Basu A; Haldar S
Int J Oncol; 2009 Jan; 34(1):281-6. PubMed ID: 19082499
[TBL] [Abstract][Full Text] [Related]
11. Cell cycle dysregulation by green tea polyphenol epigallocatechin-3-gallate.
Ahmad N; Cheng P; Mukhtar H
Biochem Biophys Res Commun; 2000 Aug; 275(2):328-34. PubMed ID: 10964666
[TBL] [Abstract][Full Text] [Related]
12. Direct inhibition of insulin-like growth factor-I receptor kinase activity by (-)-epigallocatechin-3-gallate regulates cell transformation.
Li M; He Z; Ermakova S; Zheng D; Tang F; Cho YY; Zhu F; Ma WY; Sham Y; Rogozin EA; Bode AM; Cao Y; Dong Z
Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):598-605. PubMed ID: 17372258
[TBL] [Abstract][Full Text] [Related]
13. The green tea compound, (-)-epigallocatechin-3-gallate downregulates N-cadherin and suppresses migration of bladder carcinoma cells.
Rieger-Christ KM; Hanley R; Lodowsky C; Bernier T; Vemulapalli P; Roth M; Kim J; Yee AS; Le SM; Marie PJ; Libertino JA; Summerhayes IC
J Cell Biochem; 2007 Oct; 102(2):377-88. PubMed ID: 17348027
[TBL] [Abstract][Full Text] [Related]
14. Cancer chemoprevention with green tea catechins by targeting receptor tyrosine kinases.
Shimizu M; Adachi S; Masuda M; Kozawa O; Moriwaki H
Mol Nutr Food Res; 2011 Jun; 55(6):832-43. PubMed ID: 21538846
[TBL] [Abstract][Full Text] [Related]
15. Signal transduction pathways: targets for green and black tea polyphenols.
Park AM; Dong Z
J Biochem Mol Biol; 2003 Jan; 36(1):66-77. PubMed ID: 12542977
[TBL] [Abstract][Full Text] [Related]
16. The specific anti-cancer activity of green tea (-)-epigallocatechin-3-gallate (EGCG).
Wang YC; Bachrach U
Amino Acids; 2002; 22(2):131-43. PubMed ID: 12395181
[TBL] [Abstract][Full Text] [Related]
17. Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer.
Stuart EC; Scandlyn MJ; Rosengren RJ
Life Sci; 2006 Nov; 79(25):2329-36. PubMed ID: 16945390
[TBL] [Abstract][Full Text] [Related]
18. Green tea polyphenol (-)-epigallocatechin-3-gallate inhibits cyclooxygenase-2 expression in colon carcinogenesis.
Peng G; Dixon DA; Muga SJ; Smith TJ; Wargovich MJ
Mol Carcinog; 2006 May; 45(5):309-19. PubMed ID: 16508969
[TBL] [Abstract][Full Text] [Related]
19. Protective mechanism of epigallocatechin-3-gallate against Helicobacter pylori-induced gastric epithelial cytotoxicity via the blockage of TLR-4 signaling.
Lee KM; Yeo M; Choue JS; Jin JH; Park SJ; Cheong JY; Lee KJ; Kim JH; Hahm KB
Helicobacter; 2004 Dec; 9(6):632-42. PubMed ID: 15610077
[TBL] [Abstract][Full Text] [Related]
20. Intracellular signaling network as a prime chemopreventive target of (-)-epigallocatechin gallate.
Na HK; Surh YJ
Mol Nutr Food Res; 2006 Feb; 50(2):152-9. PubMed ID: 16470647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]